Capital Advisors »

Atara Biotherapeutics shares owned by Capital Advisors

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 396 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr S&p Mc 400gr Etf (IJK)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Capital Advisors

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Bank of New York Mellon
Marshall Wace

View all funds holding Atara Biotherapeutics